Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo's Next Private Label First Lands With Second Thoughts On Outlook

Executive Summary

The launch of a private label version 24HR OTC heartburn treatment comes with Perrigo in need of another high-selling product to boost revenues in its core business, OTC private label. But analysts call for Perrigo to do more to grow in new markets.


Related Content

E-Commerce Pricing Pressures 'Manageable' To P&G, But 'Scary' To Analysts
Pricing Pressures 'Manageable' To P&G, But Threatening To Analysts
Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues
Perrigo Positioned To Prosper From Potential Amazon OTC Product Play
Perrigo’s Outgoing CEO Advocates OTC Switches, Starting With Statins
Perrigo Makes Its Rx Generics Business Look Right At Home
Private Label Competition For Zegerid OTC Sets Sail With Perrigo Launch
Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile
OTC Nexium 24HR Rides Blockbuster History Into Full Field Of Competitors


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts